← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PAI HOLDINGS PHARM · Approved 2017-11-20

Drug application

FDA Application #

ANDA208100

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN

Generic name

Erythromycin

Active ingredients

ERYTHROMYCIN

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

PAI HOLDINGS PHARM

First approval

2017-11-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown